EFFICACY AND SAFETY OF ORAL OCTREOLIN™ IN PATIENTS WITH ACROMEGALY

Registry ID

EUCTR2011-002912-10

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Chiasma, Inc.

Start date

2011-08-31

Completion date

2014-06-30

Last update

2026-08-16

Conditions

• Acromegaly

Summary

To determine the effect of Octreolin therapy on Insulin-like Growth Factor 1 (IGF-1) levels

Locations

• , , Netherlands
• , , Poland
• , , UK
• , , Germany
• , , Hungary
• , , Lithuania
• , , Slovakia
• , , Italy
• , , Slovenia

Related clinical trials

• An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
• A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
• Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
• Study of MAR002 in Healthy Men
• Effects of Pasireotide Lar Therapy on Bone Metabolism
• Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study

View on source registry